PCSK9 Inhibitors (Planet Biotechnology)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePCSK9 Inhibitors (Planet Biotechnology)

Drug Alias NameProprotein Convertase Subtilisin/Kexin Type-9 Inhibitors (Planet Biotechnology)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors

TargetsProprotein convertase subtilisin kexin type 9

Therapy Area/IndicationsHypercholesterolemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPlanet Biotechnology

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPlanet Biotechnology

Active IndicationsN/A

Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A